Kinetics of MMP-1 and MMP-3 produced by mast cells and macrophages in liver fibrogenesis of rat

Anticancer Research

Volumn 26, Issue 5 A, 2006, Pages 3517-3526

  Jeong, Won Il ^a   Do, Sun Hee ^a   Jeong, Da Hee ^a   Hong, Il Hwa ^a   Park, Jin Kyu ^a   Ran, Ki Mi ^a   Yang, Hai Jie ^a   Yuan, Dong Wei ^a   Kim, Soon Bok ^a   Cha, Myung Sook ^b   Jeong, Kyu Shik ^a  

^a Kyungpook National University   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

Fibrosis; Macrophage; Mast cell; MMP 1; MMP 3

Indexed keywords

CARBON TETRACHLORIDE; GELATINASE B; INTERSTITIAL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME KINETICS; FIBROGENESIS; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; MACROPHAGE; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CARBON TETRACHLORIDE; FIBROSIS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; KINETICS; LIVER; MACROPHAGES; MALE; MAST CELLS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; RATS; RATS, WISTAR; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 33750717503     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Nagase H and Woessner JF Jr: Matrix metalloproteinases. J Biol Chem 274: 21491-21494, 1999.
2. Benyon RC, Iredale JP, Goddard S, Winwood PJ and Arthur MJ: Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 110: 821-831, 1996.
3. Knittel T, Mehde M, Kobold D, Saile B, Dinter C and Ramadori G: Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J Hepatol 30: 48-60, 1999.
4. Zhou X, Hovell CJ, Pawley S, Hutchings MI, Arthur MJ, Iredale JP and Benyon RC: Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis. Liver Int 24: 492-501, 2004.
5. Lichtinghagen R, Breitenstein K, Arndt B, Kuhbacher T and Boker KH: Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver. Virchows Arch 432: 153-158, 1998.
6. Jeong WI, Lee CS, Park SJ, Chung JY and Jeong KS: Kinetics of macrophages, myofibroblasts and mast cells in carbon tetrachloride-induced rat liver cirrhosis. Anticancer Res 22: 869-877, 2002.
7. Cawston TE, Murphy G, Mercer E, Galloway WA, Hazleman BL and Reynolds JJ: The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J 211: 313-318, 1983.
8. Howard EW, Bullen EC and Banda MJ: Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J Biol Chem 266: 13064-13069, 1991.
9. DeClerck YA, Yean TD, Lu HS, Ting J and Langley KE: Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J Biol Chem 266: 3893-3899, 1991.
10. Jeong DH, Lee GP, Jeong WI, Do SH, Yang HJ, Yuan DW, Park HY, Kim KJ and Jeong KS: Alterations of mast cells and TGF-β1 on the silymarin treatment for CCl4-induced hepatic fibrosis. World J Gastroenterol 11: 1141-1148, 2005.
11. Arthur MJ, Stanley A, Iredale JP, Rafferty JA, Hembry RM and Friedman SL: Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity. Biochem J 287: 701-707, 1992.
12. Iredale JP, Benyon RC, Arthur MJ, Ferris WF, Alcolado R, Winwood PJ, Clark N and Murphy G: Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 24: 176-184, 1996.
13. Vyas SK, Leyland H, Gentry J and Arthur MJ: Rat hepatic lipocytes synthesize and secrete transin (stromelysin) in early primary culture. Gastroenterology 109: 889-898, 1995.
14. Theret N, Musso O, L'Helgoualc'h A, Campion JP and Clement B: Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers. Am J Pathol 153: 945-954, 1998.
15. Knittel T, Mehde M, Grundmann A, Saile B, Scharf JG and Ramador G: Expression of matrix metalloporitenases and their inhibitors during hepatic tissue repair in the rat. Histochem Cell Biol 113: 443-453, 2000.
16. Galis ZS, Sukhova GK, Lark MW and Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493-2503, 1994.
17. Galis ZS, Sukhova GK, Kranzhofer R, Clark S and Libby P: Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 92: 402-406, 1995.
18. Albin RJ, Senior RM, Welgus HG, Connolly NL and Campbell EJ: Human alveolar macrophages secrete an inhibitor of metalloproteinase elastase. Am Rev Respir Dis 135: 1281-1285, 1987.
19. Shapiro SD, Kobayashi DK and Welgus HG: Identification of TIMP-2 in human alveolar macrophages: regulation of biosynthesis is opposite to that of metalloproteinases and TIMP-1. J Biol Chem 267: 13890-13894, 1992.
20. Zhang J, Nie G, Jian W, Woolley DE and Salamonsen LA: Mast cell regulation of human endometrial matrix metalloproteinases: a mechanism underlying menstruation. Biol Reprod 59: 693-703, 1998.
21. Tetlow LC, Harper N, Dunningham T, Morris MA, Bertfield H and Woolley DE: Effects of induced mast cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitro. Ann Rheum Dis 57: 25-32, 1998.
22. Johnson JL, Jackson CL, Angelini GD and George SJ: Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 18: 1707-1715, 1998.
23. Milne SA, Rakhyoot A, Drudy TA, Brechin S, Riley SC and Critchley HO: Co-localization of matrix metalloproteinase-1 and mast cell tryptase in the human uterus. Mol Hum Reprod 7: 559-565, 2001.
24. Naesse EP, Schreurs O, Helgeland K, Schenck K and Steinsvoll S: Matrix metalloproteinases and their inhibitors in gingival mast cells in persons with and without human immunodeficiency virus infection. J Periodontal Res 38: 575-582, 2003.
25. Arthur MJ: Fibrogenesis II: metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 279: G245-G249, 2000.
26. Fiorucci S, Rizzo G, Antonelli E, Renga B, Mencarelli A, Riccardi L, Orlandi S, Pruzanski M, Morelli A and Pellicciari R: A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis. J Pharmacol Exp Ther 314: 584-595, 2005.
27. Jeong WI, Do SH, Yun HS, Song BJ, Kim SJ, Kwak WJ, Yoo SE, Park HY and Jeong KS: Hypoxia potentiates transforming growth factor-beta expression of hepatocyte during the cirrhotic condition in rat liver. Liver Int 24: 658-668, 2004.
28. Friedman SL: Mac the knife? Macrophages - the double-edged sword of hepatic fibrosis. J Clin Invest 115: 29-32, 2005.
29. Gaca MD, Pickering JA, Arthur MJ and Benyon RC: Human and rat hepatic stellate cells produce stem cell factor: a possible mechanism for mast cell recruitment in liver fibrosis. J Hepatol 30: 850-858, 1999.
30. Armbrust T, Batusic D, Ringe B and Ramadori G: Mast cells distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis. J Hepatol 26: 1042-1054, 1997.
31. Akiyoshi H and Terada T: Mast cell, myofibroblast and nerve terminal complexes in carbon tetrachloride-induced cirrhotic rat livers. J Hepatol 29: 112-119, 1998.
32. Ramos SG, Montenegro AP, Goissis G and Rossi MA: Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum-induced rat liver fibrosis. Pathol Int 44: 655-661, 1994.
33. Rioux KP, Sharkey KA, Wallace JL and Swain MG: Hepatic mucosal mast cell hyperplasia in rats with secondary biliary cirrhosis. Hepatology 23: 888-895, 1996.
34. Umezu K, Yuasa S, Sudoh A and Inagaki M: Suppressive effect of tritoqualine (TRQ) on the acceleration of fibrosis in the liver. Nippon Yakurigaku Zasshi 87: 291-300, 1986.
35. Seyer JM, Hutcheson ET and Kang AH: Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest 59: 241-248, 1997.
36. Rojkind M, Giambrone MA and Biempica L: Collagen types in normal and cirrhotic liver. Gastroenterology 76: 710-719, 1979.
37. Aimes RT and Quigley JP: Matrix metalloproteinase-2 an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific3/4- and 1/4-length fragments. J Biol Chem 270: 5872-5876, 1995.
38. Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J and Lopez-Otin C: Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269: 16766-16773, 1994.
39. Bigg HF and Rowan AD: The inhibition of metalloproteinases as a therapeutic target in rheumatoid arthritis and osteoarthritis. Curr Opin Pharmacol 1: 314-320, 2001.
40. Iredale JP, Murphy G, Hembry RM, Friedman SL and Arthur MJ: Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J Clin Invest 90: 282-287, 1992.
41. Sugihara A, Tsujimura T, Fujita Y, Nakata Y and Terada N: Evaluation of role of mast cells in the development of liver fibrosis using mast cell-deficient rats and mice. J Hepatol 30: 859-867, 1999.
42. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R and Iredale JP: Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115: 56-65, 2005.